Table 4.
Ensemble risk reduction protocol schedule of assessments and procedures
| Procedures/assessments | CRF (yes/no) |
Staff member | Time (min) | −1 | T0 | First and second month | T1 | T2 |
| Screening/ consent | Baseline/ randomisation | Ensemble versus support as usual | Post-test | Follow-up 4 months | ||||
| Oral and written information | No | Research collaborator | 20 | √ | ||||
| Consent | No | Research collaborator | 30 | √ | ||||
| Eligibility criteria assessment | Yes | Research collaborator | 10 | √ | ||||
| Sociodemographic questionnaire | Yes | Assessor | √ | |||||
| The French Zarit Burden Interview | Yes | Assessor | √ | √ | √ | |||
| Randomisation-computer generated | Yes | A specific randomisation coordinator | 10 | √ | ||||
| The Brief Symptom Inventory | Yes | Assessor | √ | √ | √ | |||
| The Life Orientation Test-Revised | Yes | Assessor | √ | √ | √ | |||
| The 36-item Medical Outcome Study Short-Form Health Survey | Yes | Assessor | √ | √ | √ | |||
| The Social and Occupational Functioning Assessment Scale | Yes | Assessor | √ | √ | ||||
| Qualitative data by 20 semi-directed interviews with participants in intervention | No | Two research collaborators | √ | |||||
| Treatment group | Yes | Intervention provider | 360 | √ | ||||
| All groups, being in touch and continuing information | No | Intervention provider | 30 | √ | ||||
| Supervision of intervention provider | No | Study coordinator | According to need | Continuously | ||||
| Termination of the study | Study coordinator | According to need | Continuously | |||||
| Serious adverse event form | Study coordinator | According to need | Continuously | |||||
| Progress notes | No | All team members | According to need | Continuously | ||||